CiteULike  View Full Text   View/Add Comment  Download reader    
Mukta Rani,Manas R. Dikhit,Ganesh C Sahoo,Pradeep Das.Journal of Biomedical Research,2011,25(2):100-110
Comparative domain modeling of human EGF-like module EMR2 and study of interaction of the fourth domain of EGF with chondroitin 4-sulphate
  
DOI£º10.1016/S1674-8301(11)60013-4
Keywords£ºEMR2, G-protein coupled receptor, transmembrane, homology modeling, EGF-TM7
Grant Program£º
¡¡¡¡ ¡¡¡¡ ¡¡¡¡ ¡¡¡¡
AuthorInstitution
Mukta Rani Biomedical Informatics Division, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna-, India
Manas R. Dikhit Biomedical Informatics Division, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna-, India
Ganesh C Sahoo Biomedical Informatics Division, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna-, India
Pradeep Das Biomedical Informatics Division, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna-, India
Hits: 2064
Download times: 1279
      
Abstract £º
      EMR2 is an EGF-like module containing mucin-like hormone receptor-2 precursor, a G-protein coupled recep-tor (G-PCR). Mutation in EMR2 causes complicated disorders like polycystic kidney disease (PKD). The struc-ture of EMR2 shows that the fifth domain is comprised of EGF-TM7 helices. Functional assignment of EMR2 by support vector machine (SVM) revealed that along with transporter activity, several novel functions are predicted. A twenty amino acid sequence "MGGRVFLVFLAFCVWLTLPG" acts as the signal peptide responsible for post-translational transport. Eight amino acids are involved in N-glycosylation sites and two cleavage sites are Leu517 and Ser518 in EMR2. The residue Arg241 is responsible for interaction with glycosaminoglycan and chondroitin sulfate. On the basis of structure, function and ligand binding sites, competitive EMR2 inhibitors designed may decrease the rate of human diseases like Usher¡¯s syndrome, bilateral frontoparietal polymicrogyria and PKD.
Close